Case Study

Aventis (B): One year after the merger

5 pages
December 2002
Reference: IMD-3-1106

In December 1999, one year after the merger of Hoechst and Rhône-Poulenc, the new company Aventis had increased its revenues, operating margins and reduced costs. It was also well-positioned to achieve some of its major strategic goals. In November 2000, Aventis announced its decision to sell of its crop sciences operations. In this way, Aventis became a focussed pharmaceuticals company.

Keywords
Mergers and Acquisitions, Pharmaceuticals, Integration
Settings
Global
December 1999
Type
Published Sources
Copyright
© 2002
Available Languages
English
Case clearing houses
IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Looking for something specific?
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics